Ryman Healthcare Limited logo

SPH Notice – Hickman Family Trustees Limited

Substantial Holder Notice2 December 2019RYMHealthcare

DISCLOSURE OF BEGINNING TO HAVE SUBSTANTIAL HOLDING
SECTION 276, FINANCIAL MARKETS CONDUCT ACT 2013


To: NZX Limited (NZX)

And: Ryman Healthcare Limited


Date this disclosure made: 2 December 2019

Date on which substantial holding began: 1 December 2019


Substantial product holder giving disclosure

Hickman Family Trustees Limited


Summary of substantial holding


Class of quoted voting products: Fully paid ordinary shares in Ryman Healthcare Limited (NZX: RYM)

(“Shares”)


Summary for:

Hickman Family Trustees Limited


For this disclosure:

(a) total number held in class: 35,000,000

(b) total in class: 500,000,000

(c) total percentage held in class: 7.0%


Details of relevant interests

Details for Hickman Family Trustees Limited


Nature of relevant interest: Registered holder of Shares


For that relevant interest:

(a) number held in class: 35,000,000

(b) percentage held in class: 7.0%

(c) current registered holder: Kevin James Hickman and Joanna Hickman

(d) registered holder once transfer is registered: Hickman Family Trustees Limited


Details of transactions and events giving rise to substantial holding

On 1 December 2019 Kevin James Hickman and Joanna Hickman retired as trustees of The Hickman

Family Trust and Hickman Family Trustees Limited was appointed as the trustee of The Hickman

Family Trust. No consideration was applicable for this change of registered holder.


Kevin James Hickman and Joanna Hickman jointly hold 100% of the shares in Hickman Family

Trustees Limited. The directors of Hickman Family Trustees Limited are Kevin James Hickman,

Joanna Hickman and Warren James Bell.


Additional information

Address(es) for substantial product holder:

Hickman Family Trustees Limited, 92C Russley Road, Christchurch 8042.


Contact details for enquiries: Brent Schumacher, (03) 336 0260, brent.schumacher@hft.net.nz.


Name of any other person believed to have given, or believed to be required to give, a disclosure

under the Financial Markets Conduct Act 2013 in relation to the financial products to which this

disclosure relates: Kevin James Hickman and Joanna Hickman

Directors’ and senior managers’ disclosure
Warren James Bell is also a director of Ryman Healthcare Limited. A separate disclosure has been,

or will be, made by Warren Bell in relation to this transaction.


Certification

I, Brent Jeffrey Schumacher, certify that, to the best of my knowledge and belief, the information

contained in this disclosure is correct and that I am duly authorised to make this disclosure by all

persons for whom it is made.

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.